Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

NCT07029776

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Not yet recruiting

TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

NCT07502872

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +10 more
Locations: Rhode Island Hospital Providence, Rhode Island, United States

View Trial Details

Not yet recruiting

Teclistamab In Waldenstrom's Macroglobulinemia

NCT07791498

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not yet recruiting

A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma

NCT05874193

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Johnston Hematology and Oncology of Clayton Clayton, North Carolina, United States

Maria Parham Hospital Henderson, North Carolina, United States

Scotland Health Care System Laurinburg, North Carolina, United States

UNC Health Southeastern Lumberton, North Carolina, United States

View Trial Details

Not yet recruiting

An Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

NCT07680166

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Single-center, Prospective, Exploratory Clinical Study

NCT07795099

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory Lymphoma

NCT07791615

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study to Evaluate Change in Disease Activity and Adverse Events of Subcutaneous Etentamig Compared With Daratumumab Plus Cyclophosphamide Plus Bortezomib Plus Dexamethasone (Dara-CyBorD) in Adults With Amyloid Light Chain (AL) Amyloidosis

NCT07793422

Conditions: Amyloid Light Chain (AL) Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Multi-CAR T Cell Therapy in the Treatment of Multiple Myeloma

NCT03271632

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Not yet recruiting

Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma

NCT06429150

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions